149 related articles for article (PubMed ID: 34189894)
1. An Unusual Case of Severe Pneumocystis Jiroveci Pneumonia (PJP) presenting as "Recurrent Cytokine Storm'' following COVID-19 Infection.
Chakravarthy KK; Cherukuri B; Anne S; Shankar TU; Mohan Reddy GM; Guttikonda N
J Assoc Physicians India; 2021 May; 69(5):78. PubMed ID: 34189894
[No Abstract] [Full Text] [Related]
2.
Gentile I; Viceconte G; Lanzardo A; Zotta I; Zappulo E; Pinchera B; Scotto R; Schiano Moriello N; Foggia M; Giaccone A; Messina G; Salvatore P; Buonomo AR; Federico Ii Covid-Team
Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769913
[TBL] [Abstract][Full Text] [Related]
3. Concurrent COVID-19 and Pneumocystis jirovecii pneumonia in a severely immunocompromised 25-year-old patient.
Bhat P; Noval M; Doub JB; Heil E
Int J Infect Dis; 2020 Oct; 99():119-121. PubMed ID: 32768700
[No Abstract] [Full Text] [Related]
4.
Viceconte G; Buonomo AR; Lanzardo A; Pinchera B; Zappulo E; Scotto R; Schiano Moriello N; Vargas M; Iacovazzo C; Servillo G; Gentile I;
Infect Dis (Lond); 2021 May; 53(5):382-385. PubMed ID: 33645461
[TBL] [Abstract][Full Text] [Related]
5. Using Routine Laboratory Markers and Immunological Indicators for Predicting
Tang G; Tong S; Yuan X; Lin Q; Luo Y; Song H; Liu W; Wu S; Mao L; Liu W; Zhu Y; Sun Z; Wang F
Front Immunol; 2021; 12():652383. PubMed ID: 33912176
[TBL] [Abstract][Full Text] [Related]
6. Fact or fiction: does the non-HIV/AIDS immunosuppressed patient need Pneumocystis jiroveci pneumonia prophylaxis? An updated literature review.
Grewal P; Brassard A
J Cutan Med Surg; 2009; 13(6):308-12. PubMed ID: 19919808
[TBL] [Abstract][Full Text] [Related]
7. [Pneumonia by Pneumocystis jirovecii after COVID-19 in non-HIV patient].
Amparo-Vicente M; Morte E
Rev Chilena Infectol; 2022 Jun; 39(3):357-360. PubMed ID: 36156700
[TBL] [Abstract][Full Text] [Related]
8. Pneumocystis jiroveci pneumonia in immunocompromised patients: delayed diagnosis and poor outcomes in non-HIV-infected individuals.
Li MC; Lee NY; Lee CC; Lee HC; Chang CM; Ko WC
J Microbiol Immunol Infect; 2014 Feb; 47(1):42-7. PubMed ID: 23063081
[TBL] [Abstract][Full Text] [Related]
9. Apical Pneumocystis jiroveci as an AIDS defining illness: A case report illustrating a change in the paradigm.
Pfeifer K; Kalra V; Adebowale A; Juthani-Mehta M; Soo-Shin M
J Radiol Case Rep; 2014 Nov; 8(11):15-24. PubMed ID: 25926907
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for Pneumocystis jiroveci pneumonia in glomerulonephritis patients receiving immunosuppressants.
Yang CY; Yang AH; Yang WC; Lin CC
Intern Med; 2012; 51(20):2869-75. PubMed ID: 23064560
[TBL] [Abstract][Full Text] [Related]
11. A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab.
Cai S; Sun W; Li M; Dong L
Clin Rheumatol; 2020 Sep; 39(9):2797-2802. PubMed ID: 32562070
[TBL] [Abstract][Full Text] [Related]
12. Pneumocystis jirovecii Pneumonia and Severe Acute Respiratory Syndrome Coronavirus 2 Coinfection in a Patient With Newly Diagnosed HIV-1 Infection.
Mang S; Kaddu-Mulindwa D; Metz C; Becker A; Seiler F; Smola S; Maßmann A; Becker SL; Papan C; Bals R; Lepper PM; Danziger G
Clin Infect Dis; 2021 Apr; 72(8):1487-1489. PubMed ID: 32607564
[No Abstract] [Full Text] [Related]
13. Cytomegaloviral or
Sun YS; Huang DF; Lin FC; Hsu CK; Sun IT; Chang SC; Tsai CY; Lai CC
J Rheumatol; 2019 Mar; 46(3):251-258. PubMed ID: 30504509
[TBL] [Abstract][Full Text] [Related]
14. Pneumocystis jirovecii pneumonia in COVID-19: an overlooked clinical entity-Response to "Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19".
Buonomo AR; Viceconte G; Gentile I
Crit Care; 2021 Dec; 25(1):418. PubMed ID: 34872608
[No Abstract] [Full Text] [Related]
15. Veno-Venous Extracorporeal Membrane Oxygenation for Severe Pneumocystis jirovecii Pneumonia in an Immunocompromised Patient without HIV Infection.
Nureki SI; Usagawa Y; Watanabe E; Takenaka R; Shigemitsu O; Abe T; Yasuda N; Goto K; Kitano T; Kadota JI
Tohoku J Exp Med; 2020 Apr; 250(4):215-221. PubMed ID: 32249237
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of Prophylaxis Against Pneumocystis jiroveci Pneumonia in Patients with Crohn's Disease.
Okafor PN; Farraye FA; Okafor AT; Erim DO
Dig Dis Sci; 2015 Dec; 60(12):3743-55. PubMed ID: 26177704
[TBL] [Abstract][Full Text] [Related]
17. Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population.
Avino LJ; Naylor SM; Roecker AM
Ann Pharmacother; 2016 Aug; 50(8):673-9. PubMed ID: 27242349
[TBL] [Abstract][Full Text] [Related]
18. [Simultaneous diagnosis and favorable evolution of infection with Pneumocystis jirovecii, SARS-CoV-2 and advanced HIV].
Larzábal FJ; Vilela A; Brusca S; Saluzzi I; Ghergo GE; Angiono MA
Medicina (B Aires); 2020; 80(5):554-556. PubMed ID: 33048801
[TBL] [Abstract][Full Text] [Related]
19. Molecular diagnosis of Pneumocystis jiroveci pneumonia in immunocompromised patients.
Jarboui MA; Sellami A; Sellami H; Cheikhrouhou F; Makni F; Ben Arab N; Ben Jemaa M; Ayadi A
Mycoses; 2010 Jul; 53(4):329-33. PubMed ID: 19496933
[TBL] [Abstract][Full Text] [Related]
20. Combination of Echinocandins and Trimethoprim/Sulfamethoxazole for the Treatment of Pneumocystis jiroveci Pneumonia After Heart Transplantation.
Lu YM; Lee YT; Chang HC; Yang HS; Chang CY; Huang CM; Wei J
Transplant Proc; 2017 Oct; 49(8):1893-1898. PubMed ID: 28923644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
